Matches in Wikidata for { <http://www.wikidata.org/entity/Q92896288> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q92896288 description "article scientifique publié en 2019" @default.
- Q92896288 description "artículu científicu espublizáu n'abril de 2019" @default.
- Q92896288 description "im April 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92896288 description "scientific article published on 05 April 2019" @default.
- Q92896288 description "wetenschappelijk artikel" @default.
- Q92896288 description "наукова стаття, опублікована 5 квітня 2019" @default.
- Q92896288 name "Update on immunogenicity in severe asthma: Experience with mepolizumab" @default.
- Q92896288 name "Update on immunogenicity in severe asthma: Experience with mepolizumab" @default.
- Q92896288 type Item @default.
- Q92896288 label "Update on immunogenicity in severe asthma: Experience with mepolizumab" @default.
- Q92896288 label "Update on immunogenicity in severe asthma: Experience with mepolizumab" @default.
- Q92896288 prefLabel "Update on immunogenicity in severe asthma: Experience with mepolizumab" @default.
- Q92896288 prefLabel "Update on immunogenicity in severe asthma: Experience with mepolizumab" @default.
- Q92896288 P1433 Q92896288-70365B79-4E1E-44F8-80C0-86D6126C1254 @default.
- Q92896288 P1476 Q92896288-14328A57-4EA0-44D3-8BD3-C848DE97940B @default.
- Q92896288 P2093 Q92896288-1650A0FA-C3BA-49F7-B83E-D64B2A855987 @default.
- Q92896288 P2093 Q92896288-4A4025A3-F20E-4495-953B-087EC412E32B @default.
- Q92896288 P2093 Q92896288-51E70F2E-0094-4C50-9C05-57B768481011 @default.
- Q92896288 P2093 Q92896288-5BC319F5-FB78-47C5-825D-16A715364F23 @default.
- Q92896288 P2093 Q92896288-8BCC9816-3C45-4050-8321-AE048280BF41 @default.
- Q92896288 P2093 Q92896288-CBC2D406-C6C9-43AA-B91A-BC85DF898F63 @default.
- Q92896288 P2093 Q92896288-EA67A125-BB6D-4824-995A-DA444269B2EE @default.
- Q92896288 P2093 Q92896288-EAC30285-B2E6-4258-BB1B-81D4CE23EDB9 @default.
- Q92896288 P304 Q92896288-6A0F10AB-E6D9-4806-9D73-88C7AAFCD482 @default.
- Q92896288 P31 Q92896288-23FCA7D4-B6EF-4C5B-89A8-A5A3417DDE52 @default.
- Q92896288 P356 Q92896288-71F824E7-7C3B-415D-82B9-D45A995CE372 @default.
- Q92896288 P433 Q92896288-59ABF5EB-A000-4D70-A6AC-CD2A416AA1F4 @default.
- Q92896288 P478 Q92896288-3FBC7EEA-9ECF-48E4-9051-CFAF1B425F50 @default.
- Q92896288 P50 Q92896288-54600C6F-3A11-495A-B0B0-F7B5DFFCD797 @default.
- Q92896288 P577 Q92896288-0E5226C1-1DF8-4959-AC3C-17E1197C7FA9 @default.
- Q92896288 P698 Q92896288-0219B9F2-823F-4753-BE1E-24456CCAB855 @default.
- Q92896288 P921 Q92896288-7CACE0DE-7AAB-4D15-AA09-0ECFF2DE5A1B @default.
- Q92896288 P356 J.JAIP.2019.03.042 @default.
- Q92896288 P698 30954640 @default.
- Q92896288 P1433 Q24056070 @default.
- Q92896288 P1476 "Update on immunogenicity in severe asthma: Experience with mepolizumab" @default.
- Q92896288 P2093 "Charlene M Prazma" @default.
- Q92896288 P2093 "Erik Meyer" @default.
- Q92896288 P2093 "Frank C Albers" @default.
- Q92896288 P2093 "Gerald J Gleich" @default.
- Q92896288 P2093 "Hector G Ortega" @default.
- Q92896288 P2093 "Koichiro Asano" @default.
- Q92896288 P2093 "Stephen A Mallett" @default.
- Q92896288 P2093 "Steve W Yancey" @default.
- Q92896288 P304 "2469-2475.e1" @default.
- Q92896288 P31 Q13442814 @default.
- Q92896288 P356 "10.1016/J.JAIP.2019.03.042" @default.
- Q92896288 P433 "7" @default.
- Q92896288 P478 "7" @default.
- Q92896288 P50 Q55233371 @default.
- Q92896288 P577 "2019-04-05T00:00:00Z" @default.
- Q92896288 P698 "30954640" @default.
- Q92896288 P921 Q35869 @default.